Scientific Events

Cancer BiologyOncologyMetastasis+2

EMBO | EMBL Symposium: Defining and Defeating Metastasis — From Plasticity to Immune Evasion to Therapy Resistance

A symposium dedicated to the biology of metastasis, one of the greatest challenges in cancer treatment. Topics include epithelial-mesenchymal transition, cancer cell plasticity, the metastatic niche, immune evasion by metastatic cells, and strategies to overcome therapy resistance in metastatic disease.

November 10 – 13, 2026

Heidelberg, Germany

Cancer BiologyOncologyImmunotherapy+2

Seminar

EMBO | FEBS Lecture Course: Cancer Research — From Fundamental Insights to Clinical Application

An intensive lecture course bridging fundamental cancer biology and clinical oncology. Topics include oncogene and tumour suppressor biology, cancer metabolism, the tumour microenvironment, immunotherapy mechanisms, and the translation of basic discoveries into clinical trials and approved therapies.

August 17 – 23, 2026

Spetses, Greece

OncologyCancer BiologyImmunotherapy+2

JCA-AACR Special Joint Conference: Novel Therapies and Diagnostics in Upper Digestive and Head and Neck Cancers

A joint conference of the Japanese Cancer Association and AACR focusing on cancers of the upper digestive tract and head and neck region. Topics include the molecular biology of oesophageal, gastric, and head and neck cancers, emerging immunotherapy approaches, and novel diagnostic biomarkers.

June 27 – 29, 2026

Kyoto, Japan

Philadelphia, Pennsylvania, United States

Advances in Malignant Lymphoma: From Discovery to Clinical Impact

A conference on the biology and treatment of malignant lymphomas, covering Hodgkin and non-Hodgkin lymphoma, chronic lymphocytic leukaemia, and multiple myeloma. Topics include the molecular pathogenesis of lymphoid malignancies, CAR-T cell therapies, bispecific antibodies, and novel combination regimens.

June 24 – 27, 2026

OncologyHaematologyLymphoma+2

Cancer BiologyOncologyTumour Biology+2

EACR 2026 Congress: Innovative Cancer Science

The biennial congress of the European Association for Cancer Research, bringing together thousands of cancer researchers from across Europe and beyond. The 2026 congress focuses on innovative approaches in cancer science, from fundamental discoveries in tumour biology to translational breakthroughs and emerging clinical applications.

June 8 – 11, 2026

Budapest, Hungary

San Diego, California, United States

AACR Annual Meeting 2026

The world's largest cancer research meeting, bringing together scientists, clinicians, and advocates from across the globe. The AACR Annual Meeting features thousands of presentations covering all aspects of cancer research, from fundamental biology to clinical trials, with special sessions on emerging technologies and translational breakthroughs.

April 17 – 22, 2026

Cancer BiologyOncologyTranslational Research+2

Boston, Massachusetts, United States

IMMUNOLOGY2026™ — AAI Annual Meeting

The 109th annual meeting of the American Association of Immunologists, bringing together immunologists from around the world to share the latest discoveries in immunology. The meeting features keynote lectures, symposia, workshops, and poster sessions covering all aspects of basic and translational immunology.

April 15 – 19, 2026

ImmunologyInnate ImmunityAdaptive Immunity+2

Philadelphia, Pennsylvania, United States

AACR Special Conference: Innovations in Kidney Cancer Research — From Molecular Insights to Therapeutic Breakthroughs

A conference on the latest advances in kidney cancer biology and treatment. Topics include the molecular landscape of renal cell carcinoma, the role of the VHL pathway, immunotherapy in kidney cancer, combination therapy strategies, and emerging targets for drug development.

March 13 – 16, 2026

Cancer BiologyOncologyKidney Cancer+2

Los Angeles, California, United States

AACR Immuno-Oncology Conference (AACR IO): Discovery and Innovation in Cancer Immunology

A premier conference on cancer immunology and immunotherapy, covering the latest discoveries in tumour immunology and their translation into clinical practice. Topics include checkpoint inhibitors, CAR-T cell therapies, cancer vaccines, the tumour microenvironment, and combination immunotherapy strategies.

February 18 – 21, 2026

ImmunotherapyCancer BiologyOncology+2